Eva Tomero

1.8k total citations
31 papers, 470 citations indexed

About

Eva Tomero is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Eva Tomero has authored 31 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Rheumatology, 15 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Eva Tomero's work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Eva Tomero is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Eva Tomero collaborates with scholars based in Spain, Switzerland and United States. Eva Tomero's co-authors include Rosario García‐Vicuña, Isidoro González‐Álvaro, A Laffón, Ana M. Ortiz, Loreto Carmona, Vera Ortiz-Santamaría, M.Á. Descalzo, Antonio Fernández‐Nebro, Juan Mulero and Eduardo Collantes‐Estévez and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The American Journal of Medicine.

In The Last Decade

Eva Tomero

29 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Tomero Spain	12	304	153	114	112	78	31	470
Haruka Tsuchiya Japan	14	188 0.6×	196 1.3×	80 0.7×	111 1.0×	69 0.9×	31	512
Yoshie Sanayama Japan	10	332 1.1×	171 1.1×	56 0.5×	79 0.7×	95 1.2×	17	582
Andrea Váncsa Hungary	12	305 1.0×	139 0.9×	307 2.7×	106 0.9×	40 0.5×	29	566
Olga Kryštůfková Czechia	13	153 0.5×	146 1.0×	190 1.7×	146 1.3×	22 0.3×	36	458
Rasho Rashkov Bulgaria	12	250 0.8×	173 1.1×	40 0.4×	74 0.7×	47 0.6×	47	475
Jacques Éric Gottenberg France	8	195 0.6×	169 1.1×	52 0.5×	66 0.6×	34 0.4×	12	567
Noémie Assous France	8	204 0.7×	136 0.9×	104 0.9×	103 0.9×	32 0.4×	11	481
Hidetoshi Kaneoka Japan	13	203 0.7×	81 0.5×	70 0.6×	172 1.5×	67 0.9×	22	478
Miaojia Zhang China	12	229 0.8×	185 1.2×	58 0.5×	118 1.1×	33 0.4×	23	547
Shabina Sultan United Kingdom	10	441 1.5×	157 1.0×	388 3.4×	98 0.9×	74 0.9×	12	729

Countries citing papers authored by Eva Tomero

Since Specialization

Citations

This map shows the geographic impact of Eva Tomero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tomero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tomero more than expected).

Fields of papers citing papers by Eva Tomero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Tomero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tomero. The network helps show where Eva Tomero may publish in the future.

Co-authorship network of co-authors of Eva Tomero

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tomero. A scholar is included among the top collaborators of Eva Tomero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tomero. Eva Tomero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

González‐Álvaro, Isidoro, Eva Tomero, Rosario García‐Vicuña, et al.. (2024). Regulation of monocyte apoptosis and DNA extrusion in monocyte extracellular traps by PSGL-1: Relevance in systemic lupus erythematosus. Translational research. 274. 10–20. 3 indexed citations

Muñoz‐Calleja, Cecilia, Isidoro González‐Álvaro, Eva Tomero, et al.. (2024). PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study. Frontiers in Immunology. 15. 1403104–1403104. 1 indexed citations

Rúa‐Figueroa, Íñigo, Eva Tomero, Tarek Carlos Salman-Monte, et al.. (2023). Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist’s judgement?. Lara D. Veeken. 63(1). 72–78.

González‐Álvaro, Isidoro, Eva Tomero, Rosario García‐Vicuña, et al.. (2023). Low P-Selectin Glycoprotein Ligand-1 Expression in Neutrophils Associates with Disease Activity and Deregulated NET Formation in Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 24(7). 6144–6144. 9 indexed citations

Galindo-Izquierdo, María, José María Pego‐Reigosa, Alejandro Olivé Marquès, et al.. (2022). Clinical characteristics and risk factors associated with lymphoma in patients with systemic lupus erythematosus: a nationwide cohort study. Lara D. Veeken. 62(1). 217–224. 5 indexed citations

Roy‐Vallejo, Emilia, Eva Tomero, Núria Montés, et al.. (2022). Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis. Journal of Clinical Medicine. 11(21). 6313–6313. 6 indexed citations

Castañeda, Santos, et al.. (2020). Síndrome de Cogan: análisis descriptivo y experiencia clínica de 7 casos diagnosticados y tratados en 2 hospitales de tercer nivel. Reumatología Clínica. 17(6). 318–321. 3 indexed citations

Castañeda, Santos, et al.. (2020). Cogan syndrome: Descriptive analysis and clinical experience of 7 cases diagnosed and treated in two third level hospitals. Reumatología Clínica (English Edition). 17(6). 318–321. 4 indexed citations

Lamana, Amalia, Mar Carrión, Selene Pérez‐García, et al.. (2020). Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence. Cells. 9(12). 2592–2592. 5 indexed citations

10.

Nuño, Laura, Beatriz Joven, Patrícia Carreira, et al.. (2017). Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. Rheumatology International. 37(11). 1853–1861. 48 indexed citations

11.

Ortea, Ignacio, Bernd Roschitzki, Rosario López‐Rodríguez, et al.. (2016). Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study. PLoS ONE. 11(4). e0153140–e0153140. 16 indexed citations

12.

Rúa‐Figueroa, Íñigo, José María Pego‐Reigosa, Francisco Javier López-Longo, et al.. (2015). SAT0391 Cumulative Incidence and Clinical Meaning of Severe Infection in a Large Spanish Cohort of Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 74. 801–801.

13.

Tomero, Eva, Carmen Martínez, Rosario García‐Vicuña, et al.. (2015). Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity. Journal of Molecular Neuroscience. 56(3). 577–584. 12 indexed citations

14.

Fernández-Espartero, Cruz, Eugenio de Miguel, Estíbaliz Loza, et al.. (2013). Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Annals of the Rheumatic Diseases. 73(7). 1350–1355. 49 indexed citations

15.

Tomero, Eva, Juan Mulero, Eugenio de Miguel, et al.. (2013). Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. Lara D. Veeken. 53(2). 353–360. 26 indexed citations

16.

Tomero, Eva, M.Á. Descalzo, Andrés Ponce, et al.. (2011). Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry. Lara D. Veeken. 50(11). 1999–2004. 41 indexed citations

17.

González‐Álvaro, Isidoro, Ana M. Ortiz, José María Álvaro‐Gracia, et al.. (2011). Interleukin 15 Levels in Serum May Predict a Severe Disease Course in Patients with Early Arthritis. PLoS ONE. 6(12). e29492–e29492. 50 indexed citations

18.

González‐Álvaro, Isidoro, et al.. (2009). El bloqueo terapéutico del factor de necrosis tumoral disminuye la concentración sérica de interleucina 15 en pacientes con artritis reumatoide. Reumatología Clínica. 5(1). 23–27. 1 indexed citations

19.

González‐Álvaro, Isidoro, Ana M. Ortiz, Eva Tomero, et al.. (2007). Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists. Annals of the Rheumatic Diseases. 66(12). 1675–1678. 49 indexed citations

20.

Fernández‐Nebro, Antonio, Eva Tomero, Vera Ortiz-Santamaría, et al.. (2005). Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. The American Journal of Medicine. 118(5). 552–556. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact